[Form 4] WORTHINGTON ENTERPRISES, INC. Insider Trading Activity
Rhea-AI Filing Summary
The reporting person, Michael J. Endres, a director of Worthington Enterprises, Inc. (WOR), reported two transactions on 09/25/2025. He was granted 4,035 restricted shares under the Worthington 2025 Equity Plan for Non-Employee Directors; those shares vest on the earlier of the first anniversary of the grant date or the next annual shareholders meeting. Separately, he acquired 10,000 common shares at a price of $52.95, bringing his direct beneficial ownership to 95,524 shares. The Form 4 was signed by an attorney-in-fact on 09/26/2025.
Positive
- Director purchase of 10,000 shares at $52.95 increases direct ownership to 95,524 shares, signaling insider confidence
- Grant of 4,035 restricted shares aligns the director's interests with shareholders and vests within a short, transparent period
Negative
- None.
Insights
TL;DR: Director purchased shares and received a standard restricted-stock award, modestly increasing direct ownership.
The Form 4 discloses a routine director equity grant and a market purchase by the director. The 4,035 restricted shares vest on a near-term schedule (one year or next annual meeting), which indicates standard alignment of director compensation with shareholder interests. The 10,000-share purchase at $52.95 is an outright acquisition that increases direct ownership to 95,524 shares. These actions are customary and typically viewed as neutral-to-mildly positive signals about insider sentiment, but the filing does not include information on transaction size relative to total outstanding shares or any change in control or material corporate action.
TL;DR: Compensation and purchase follow standard governance practices; vesting terms are short and clearly disclosed.
The restricted stock award was granted under the company's 2025 Equity Plan for Non-Employee Directors with vesting tied to a one-year horizon or the next annual meeting, which is a common retention and alignment mechanism. The Form 4 shows direct filings and provides clear attribution of ownership form and vesting conditions. There is no indication of accelerated vesting, special treatment, or related-party transactions beyond normal director compensation and open-market buying.